Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 15.3% in First Three Quarters of 2022

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 112.6 million yuan in the first three quarters of 2022, up 15.3% year-on-year.

Meanwhile, the company posted 902 million yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 940.6 million yuan in total liabilities, with a liability-to-asset ratio of 17.4%.